Skip to main content
SpringerLink
Log in

Reply to Letter to the Editor Concerning “Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA”

  • Peritoneal Surface Malignancy
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chiu C-C. Letter to the Editor of Annals of Surgical Oncology Concerning “Safety and Efcacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA”. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14595-w

  2. Yurttas C, et al. Systematic review of variations in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastasis from colorectal cancer. J Clin Med. 2018;7:567.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Morano WF, Khalili M, Chi DS, Bowne WB, Esquivel J. Clinical studies in CRS and HIPEC: trials, tribulations, and future directions—a systematic review. J Surg Oncol. 2018;117:245–59.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, City of Hope National Medical Center, Duarte, CA, USA

    Kevin M. Sullivan MD, Thanh Dellinger MD & Mustafa Raoof MD

  2. Department of Surgery, Northwell Health, New York, NY, USA

    Richard L. Whelan MD & Danielle DePeralta MD

  3. Department of Surgery, Mayo Clinic, Jacksonville, FL, USA

    Amit Merchea MD

Authors
  1. Kevin M. Sullivan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard L. Whelan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Danielle DePeralta MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amit Merchea MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Thanh Dellinger MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mustafa Raoof MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mustafa Raoof MD.

Ethics declarations

Disclosures

Richard Whelan is a consultant for Applied Medical Corporation, which makes laparoscopic tocars used by some surgeons for PIPAC cases. Consulting work relates to advanced colonoscopy education and not peritoneal metastases or PIPAC. Kevin M. Sullivan, Danielle DePeralta, Amit Merchea, Thanh Dellinger, and Mustafa Raoof have no disclosures to declare in relation to this letter.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sullivan, K.M., Whelan, R.L., DePeralta, D. et al. Reply to Letter to the Editor Concerning “Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA”. Ann Surg Oncol 31, 2408–2409 (2024). https://doi.org/10.1245/s10434-024-14934-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-024-14934-5

Search

Navigation